Baxter Healthcare Corp., a subsidiary of Baxter International Inc., has signed a 12-year lease for 200,000 square feet in Cambridge.
Baxter plans to establish a new global innovation and research and development (R&D) center at the site at 650 East Kendall St. for its biopharmaceuticals business, which is expected to become a separate, independent global company known as Baxalta Incorporated in mid-2015.
The East Kendall Street building, which is owned by BioMed Realty Trust through a joint venture with Prudential Real Estate Investors, is a 282,000-square-foot life science facility that is supported by six levels of below-grade parking. Designed by architect Paul Zejfen, the building features a spacious atrium with stairs connecting its six floors of laboratory and office space, interior balconies and exterior terraces. The building received Gold status certification by the Leadership in Energy and Environmental Design of the U.S. Green Building Council. The building is 100 percent occupied.
"We are very proud to welcome Baxter to Kendall Square and our 650 East Kendall building. Baxter is a global healthcare leader with an amazing track record of scientific achievement, commercialization and corporate responsibility," Alan D. Gold, BioMed Realty’s chairman and CEO, said in a statement. "By forging this long-term connection with Baxter in Cambridge, we have the opportunity to support their technological expertise and scientific innovation for many years to come, and we look forward to providing the best environment for their business and employees to continue their great work."
Baxter plans to establish a new global innovation and research and development (R&D) center at the site at 650 East Kendall St. for its biopharmaceuticals business, which is expected to become a separate, independent global company known as Baxalta Incorporated in mid-2015.
The East Kendall Street building, which is owned by BioMed Realty Trust through a joint venture with Prudential Real Estate Investors, is a 282,000-square-foot life science facility that is supported by six levels of below-grade parking. Designed by architect Paul Zejfen, the building features a spacious atrium with stairs connecting its six floors of laboratory and office space, interior balconies and exterior terraces. The building received Gold status certification by the Leadership in Energy and Environmental Design of the U.S. Green Building Council. The building is 100 percent occupied.
"We are very proud to welcome Baxter to Kendall Square and our 650 East Kendall building. Baxter is a global healthcare leader with an amazing track record of scientific achievement, commercialization and corporate responsibility," Alan D. Gold, BioMed Realty’s chairman and CEO, said in a statement. "By forging this long-term connection with Baxter in Cambridge, we have the opportunity to support their technological expertise and scientific innovation for many years to come, and we look forward to providing the best environment for their business and employees to continue their great work."
